Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
Titel:
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
Auteur:
Howard Jr, James F Utsugisawa, Kimiaki Benatar, Michael Murai, Hiroyuki Barohn, Richard J Illa, Isabel Jacob, Saiju Vissing, John Burns, Ted M Kissel, John T Muppidi, Srikanth Nowak, Richard J O'Brien, Fanny Wang, Jing-Jing Mantegazza, Renato